Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Largely Stands Pat In Revised ANDA Submission Guidance

Dec 23 2016

• By Michael Cipriano

FDA entrance sign 2016

Related Content

ANDAs Get More Time – Or Maybe Less – To Correct Minor Deficiencies

Sep 17 2014

Related Companies

Apotex Inc.

Viatris Inc.

Novartis AG

Hospira, Inc.

Sun Pharmaceutical Industries Ltd.

Par Pharmaceutical Companies Inc.

Additional Topics

United States Generic Drugs Drug Review Regulation BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window